A Prospective Multi-center Phase III Randomized Controlled Trial
Status:
Unknown status
Trial end date:
2020-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the overall toxicity value（OTV）, PFS, ORR and OS
on advanced adenocarcinoma treated with nadaplatin or cisplatin combined with pemetrexed.